Dr. Dmitry Khasak, MD
Dermatology (Dermatology Physician)
- Medicare participating
At a glance
- Medical school
- New York University School of Medicine (1992)
- Years since graduation
- 34
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 993
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1992Medical school: New York University School of Medicine
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Dermatology Physician primary
NY license 1940541 · NJ license 25MA06377000
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Medical groups
- Century Medical and Dental Center Inc (109 clinicians)
- W Medical LLC (5 clinicians)
- Dmitry Khasak MD PC Inc (3 clinicians)
- Dmitry Khasak MD PC (3 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 993
- Services billed
- 8,781
- Patients’ average age
- 74
| Service | Times | Patients |
|---|---|---|
| Test for allergy using skin patch | 3,640 | 59 |
| Established patient office or other outpatient visit, 20-29 minutes | 2,355 | 789 |
| Injection into skin growth, more than 7 growths | 514 | 140 |
| Biopsy of related skin growth, each additional growth | 505 | 215 |
| Biopsy of related skin growth, first growth | 493 | 398 |
| New patient office or other outpatient visit, 30-44 minutes | 342 | 339 |
| Destruction of precancer skin growth, 15 or more growths | 333 | 137 |
| Destruction of precancer skin growth, 2-14 growths | 224 | 22 |
| Acne surgery | 53 | 12 |
| Injection of drug or substance under skin or into muscle | 35 | 17 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Ketoconazole Other prescribers in New York, NY | 1,236 |
| Ciclopirox Other prescribers in New York, NY | 1,231 |
| Metronidazole Other prescribers in New York, NY | 1,214 |
| Gentamicin Sulfate Other prescribers in New York, NY | 871 |
| Tacrolimus Other prescribers in New York, NY | 558 |
| Tavaborole | 534 |
| Fluocinonide Other prescribers in New York, NY | 495 |
| Pimecrolimus | 468 |
| Finasteride Other prescribers in New York, NY | 453 |
| Clobetasol Propionate Other prescribers in New York, NY | 446 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 19 companies reported 80 payments worth $2,297 in total to this clinician.
| Sun Pharmaceutical Industries Inc. | $326 |
|---|---|
| Amgen Inc. | $320 |
| AbbVie Inc. | $209 |
| Organon LLC | $207 |
| Almirall LLC | $203 |
| Regeneron Healthcare Solutions, Inc. | $198 |
| Genzyme Corporation | $176 |
| Arcutis Biotherapeutics, Inc. | $144 |
| Food and Beverage | $2,297 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.